PharmaEngine, Inc. Announces Consolidated Revenue Results for the Month and Year Ended December 2023
For the year, the company announced consolidated revenue of TWD 767,669,000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
93.8 TWD | -1.68% |
|
-1.05% | -11.09% |
05-02 | PharmaEngine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-24 | PharmaEngine, Inc. Announces First Patient Dosed in Phase I Trial of PEP07 for Solid Tumors | CI |
1st Jan change | Capi. | |
---|---|---|
-11.09% | 416M | |
+35.25% | 51.07B | |
-8.18% | 38.78B | |
+35.11% | 38.61B | |
-8.98% | 27.32B | |
+11.54% | 26.35B | |
-19.18% | 19.46B | |
+40.70% | 13.58B | |
+30.46% | 12.46B | |
-4.13% | 11.75B |